---
title: "DAJIAWEIKANG released its 2024 annual performance, with a net profit attributable to the parent company of 26.5749 million yuan, a decrease of 22.52%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236675936.md"
description: "DAJIAWEIKANG released its 2024 annual report, with operating revenue of 5.233 billion yuan, a year-on-year increase of 34.07%. The net profit attributable to shareholders was 26.5749 million yuan, a year-on-year decrease of 22.52%. The net profit after deducting non-recurring gains and losses was 25.6061 million yuan, a year-on-year decrease of 25.40%. The basic earnings per share were 0.13 yuan, and it plans to distribute a cash dividend of 0.818 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-04-20T08:42:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236675936.md)
  - [en](https://longbridge.com/en/news/236675936.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236675936.md)
generator: "portal-rs"
---

# DAJIAWEIKANG released its 2024 annual performance, with a net profit attributable to the parent company of 26.5749 million yuan, a decrease of 22.52%

According to the Zhitong Finance APP, DAJIAWEIKANG (301126.SZ) released its annual report for 2024, reporting an operating income of 5.233 billion yuan, a year-on-year increase of 34.07%. The net profit attributable to shareholders of the listed company was 26.5749 million yuan, a year-on-year decrease of 22.52%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 25.6061 million yuan, a year-on-year decrease of 25.40%. The basic earnings per share were 0.13 yuan. In addition, it plans to distribute a cash dividend of 0.818 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [301126.CN](https://longbridge.com/en/quote/301126.CN.md)

## Related News & Research

- [REG - Frontier Developmnts - Notice of FY26 Financial Results](https://longbridge.com/en/news/297272100.md)
- [MedicalRite Announces COVID-19 & Flu Combo Test for Better Health](https://longbridge.com/en/news/297204162.md)
- [RCS - Vivo Energy Limited - Notice of Meeting – 2026 Interim Results](https://longbridge.com/en/news/297161642.md)
- [CSPC says FDA clears RSV vaccine candidate SYS 6057 for US clinical trial](https://longbridge.com/en/news/296903628.md)
- [FDA allows marketing of Juul's new e-cigarettes and flavored pods](https://longbridge.com/en/news/297362439.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**